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Abstract 
Background: To evaluate the effect of monounsaturated 
fatty acid and phenolic compounds enriched extra virgin 
olive oil on correction of dyslipidemia in diabetic rats.   
Methods:  In this randomized control trial eighty albino 
rats of Sprague-Dawley strain weighing 200-250 grams 
were randomly divided into two groups of 40 rats each. 
Rats were made diabetic by injecting streptozotocin. 
Group 1 and Group 2 were given normal rodent diet and 
extra virgin olive oil supplemented diet respectively for 06 
weeks.  At the end of experimentation lipid profile was 
measured.  
Results: There was significant increase of high density 
lipoprotein and significant decrease of serum total 
cholesterol, serum triglycerides and low density 
lipoprotein of Group II rats when it was compared with 
Group I (control). 
Conclusion: Extra virgin olive oil can significantly 
improve lipid profile in diabetic rats.  
Key Words: Diabetes mellitus; Dyslipidemia; Olive oil; 
Sprague-Dawley rats. 
 
Introduction 
 
        Diabetes mellitus (DM) is documented as a group 
of heterogeneous disorders characterized by chronic 
hyperglycemia with disturbances in fat, carbohydrate 
and protein metabolism resulting from defects in 
insulin secretion, action or both. Abnormal lipid 
profile is often seen in patients with diabetes because 
insulin regulates several steps of lipid metabolism.  
Dyslipidemia in diabetics is often characterized by 
elevated fasting and postprandial levels of triglyceride 
(TG), a significant decrease in the high density 
lipoprotein (HDL). The reason for elevated plasma TG 
level is excessive production of very low density 
lipoprotein (VLDL). This over production of VLDL 
and TG in the liver has been proposed to be driven by 
high levels of serum free fatty acids (FFAs) in patients 
with insulin resistance. Increases in plasma TG 
concentration are usually associated with low HDL 
concentrations. It is now evident that hyperglycemia 
and dyslipidemia particularly high TG and low 
density lipoprotein (LDL) are risk factors for the 
development of microvascular and macrovascular 
complications in diabetic subjects.  1 
       In diabetes, inculcation of benign therapeutics 
with minimal side effects  are under consideration. 
Olive oil has been traditionally used for wide range of 
clinical diseases without unveiling underling 
mechanism. These diseased conditions include 
neurodegenerative diseases, diabetes, obesity, 
atherosclerosis, cardiovascular disease, metabolic 
syndrome and certain types of cancer mainly breast, 
colorectal and prostate cancers. Extra virgin olive oil 
(EVOO) is extracted from olive and is regarded as 
healthy dietary oil because of its high concentration of 
monounsaturated fatty acid (MUFA) and phenolic 
compounds, which have tangible health benefits. It has 
been reported that each 100 g of EVOO contains 73.7 g 
of MUFA and 50 mg of polyphenols. 2 
 
Materials and Methods 
       This randomized control trial was conducted in 
the Department of Biochemistry and Molecular 
Biology, Army Medical College, Rawalpindi in 
collaboration with Centre for Research in 
Experimental & Applied Medicine (CREAM), Army 
Medical College and National Institute of Health 
(NIH), Islamabad from March 2010 to June 2011.  This 
study was carried on eighty, 60-90 days old Albino rats 
of Sprague Dawley strain, weighing between 200-250g. 
Rats were obtained from the animal house of the NIH, 
Islamabad and were kept at its animal house. Rats 
were made diabetic by injecting streptozotocin (STZ) 
40-mg/kg/body weight intraperitoneally dissolved in 
citrate buffer. On the third day, their fasting blood 
glucose was measured by taking blood from tail veins 
under aseptic measures. Rats with blood glucose level 
more than 126 mg/dl were considered as diabetic and 
were used in study. The diabetic rats were randomly 
divided into two groups of 40 rats each. In Group -
1(Diabetic Control Group)forty diabetic rats  were fed 
with  standard pelleted diet as per requirement, 
prepared at NIH, Islamabad, according to the 
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international standards for 06 weeks. In Group- 2 
(Diabetic Experimental Group) forty diabetic rats were 
fed with EVOO supplemented diet as per requirement, 
prepared at NIH, Islamabad, for 06 weeks. EVOO 
supplemented diet is the diet containing 100 grams 
EVOO per kilogram of pelleted diet.  
Rats were kept under standard conditions 
with a daily photo period of 12 hours light and 12 
hours dark at 23 ± 2º C. Five animals were kept in one 
iron cage. All groups had free access to food and 
water. At the end of experiment, fasting blood samples 
were drawn through intracardiac puncture for 
measurement of lipid profile. Serum total cholesterol 
(TC), TG and HDL were measured by using 
commercial kits, in accordance with the instructions of 
the manufacturers, by applying the enzymatic 
colorimetric principle. LDL was calculated by using 
Friedewald formula (LDL = TC – [HDL + TG/5]). 3 
 
Results 
Results of fasting lipid profile (TC, TG.LDL 
&HDL) of Group I and II rats revealed significant 
increase of HDL and significant decrease of serum TC, 
TG and LDL of group II rats when it was compared 
with group I (control). (Table-1) 
 
Table-1: Comparison of lipid profile  
Parameters 
Control 
Group 1 
(n=40) 
Extra virgin 
olive oil 
Group 2  
(n=40) 
p Value 
Total 
Cholesterol 
(mg/dl) 
155.50 ± 17.24 124.40 ± 13.79 < 0.05 
Triglyceride 
(mg/dl) 104.52 ± 13.62 83.61 ± 10.89 < 0.05 
High Density 
Lipoproteins 
(mg/dl) 
79.36 ± 7.47 99.20 ± 9.34 < 0.05 
Low Density 
Lipoproteins 
(mg/dl) 
51.60 ± 7.33 41.28 ± 5.86 < 0.05 
The values are expressed as mean ± SD 
 
Discussion 
       Currently available synthetic drugs for treatment 
of DM include insulin and various oral anti diabetic 
agents, which are often associated with side effects 
including hypoglycemia, anemia, GIT disturbances, 
weight gain, lactic acidosis, hepatic dysfunction and 
create problem of cost effectiveness. World Health 
Organization (WHO) has now encouraged the 
evaluation of plants effective in different diseases in 
order to minimize side effects.4 Drugs made from 
plant extracts are considered to be less toxic and 
proved free from side effects associated with synthetic 
drugs. EVOO is a potent plant extract.Its effects in 
animals and humans revealed successful management 
of diabetes and its complications.  
       The serum lipid profile levels are usually elevated 
in diabetics, which increase the risk of coronary heart 
diseases.  It has now been well established that 
elevated levels of TC and LDL are cardiovascular risk 
factors, however, increased level of HDL maintains 
protective and anti-inflammatory properties. 
Therefore, benign medication with positive regulation 
for HDL and negative regulation for LDL and TG will 
be considered as therapeutic choice. EVOO improves 
lipid profile because of high concentration of MUFA 
and phenolic compounds both having a lipid lowering 
action and prevents LDL oxidation. Epidemiological 
studies also suggest that Mediterranean diet rich in 
olive oil decreases the risk of cardiovascular disease 
and improves its major risk factors. 5-7 
       Studies comparing the effect of oil containing 
saturated fatty acids & MUFA in healthy persons 
found that MUFA rich oil significantly improved lipid 
profile. Evaluation of efficacy of groundnut oil on lipid 
levels of rats, propounded MUFA as central metabolite 
countering dyslipidemia. Experimental studies in 
rabbits, rats and diabetic humans show that MUFAs 
rich diets significantly improve lipid profile.8,9 
Phenolic compounds are found to have beneficial 
effects on plasma lipoproteins, inflammatory markers 
and oxidative damage . Olive oil is found to have 
antihyperlipidemic, antithrombotic and antiathero-
sclerotic properties. 10-14 
 
Conclusion 
Medical nutrition therapies need an evaluation in 
management of dyslipidemias  
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